Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05619497 · ClinicalTrials.gov registry record · NA
The OPENS Trial: Offering Women PrEP (Aim 2)
A NA study of Human Immunodeficiency Virus and Sexually Transmitted Diseases, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 141
- Enrollment target
- 1
- Study location
NCT05619497 is a NA study of Human Immunodeficiency Virus and Sexually Transmitted Diseases that has completed, run by University of California, San Francisco. The registered enrollment target is 141 participants, below the 180-participant average among 39 other Human Immunodeficiency Virus trials with a reported enrollment target (22% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05619497, a NA study of Human Immunodeficiency Virus and Sexually Transmitted Diseases, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 141 participants
- Enrollment target
- 1
- Study location
Study Summary
To address the significant barriers to pre-exposure prophylaxis (PrEP) implementation for cisgender women and address racial inequities in HIV prevention in the United States (US), a novel approach that accounts for multilevel influences is necessary. This study is the second part (Aim 2) of a multi-component project and involves a patient- and clinic-level intervention in a public health family planning clinic in Duval County Florida, where most patients are women of color. The area has one of the highest HIV incidence rates among women in the US. The investigators developed 1) a tablet-based decision support tool (DST) that helps users learn about HIV vulnerabilities and HIV prevention strategies to inform how they consider options for reducing their likelihood of acquiring HIV, and 2) clinic-wide trainings regarding shared decision making and trauma informed care. In Aim 1 (previously completed), participants were randomized to viewing an HIV prevention DST in a clinic that had not received clinic-wide trainings. In Aim 2 (the present study), there will be two phases. In the first phase, participants will receive care at the clinic following training; the DST will not be used. In the second phase, in addition to being seen at a clinic-site that has experienced the training, participants will use the DST before their visit. Participants will be surveyed about experiences with HIV prevention counseling, intentions about using HIV prevention, and DST use (among those in the active arm in the second phase). A subset of participants, individuals who self-identify as Black or Latinx, will also complete a post-clinic visit interview. The investigators will assess whether participants initiated an HIV prevention method three months following their initial visit. The main outcomes will include a quantitative and qualitative assessment of PrEP or other HIV prevention use, decisional certainty, and satisfaction with information about HIV prevention options.
Conditions Studied
Interventions
- OTHER Clinic-wide Trainings
- OTHER Clinic-wide Trainings and HIV Prevention Decision Support Tool (DST)
- OTHER Standard Care with the HIV Prevention Decision Support Tool (DST)
Study Locations (1)
Florida
- Florida Department of Health, Duval County - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2022-12-02 |
| Est. Completion | 2024-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05619497
The ClinicalTrials.gov registry entry for NCT05619497 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 141 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 180-participant average among 39 other Human Immunodeficiency Virus trials with a reported enrollment target (22% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Human Immunodeficiency Virus appearing as the primary indexed condition, and to 3 interventions - of which Clinic-wide Trainings is the first listed.
NCT05619497 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT05619497 about?
NCT05619497 is a clinical study titled "The OPENS Trial: Offering Women PrEP (Aim 2)". To address the significant barriers to pre-exposure prophylaxis (PrEP) implementation for cisgender women and address racial inequities in HIV prevention in the United States (US), a novel approach that accounts for multilevel influences is necessary. This study is the second part (Aim 2) of a multi...
What is the current status of trial NCT05619497?
This trial is currently completed. It is a NA study. The enrollment target is 141 participants. The study started on 2022-12-02. Estimated completion is 2024-11-01.
What conditions does trial NCT05619497 study?
This clinical trial studies the following conditions: Human Immunodeficiency Virus, Sexually Transmitted Diseases, Human Immunodeficiency Virus Transmission.
What interventions are being tested in trial NCT05619497?
The interventions under investigation include: Clinic-wide Trainings (OTHER), Clinic-wide Trainings and HIV Prevention Decision Support Tool (DST) (OTHER), Standard Care with the HIV Prevention Decision Support Tool (DST) (OTHER).
Who is sponsoring clinical trial NCT05619497?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05619497 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Immunodeficiency Virus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
Gut Microbiota-Mediated Inflammatory Interactions Between AUD and HIV Infection
RECRUITING · NA
-
Increasing PrEP Use in High-Risk Social Networks of African-American MSM in Underserved Low-Risk Cities
ACTIVE NOT RECRUITING · NA
-
Integration of Hypertension Management Into HIV Care in Nigeria
ACTIVE NOT RECRUITING · NA
-
Cross-disciplinary HIV Integrated Mental Health Support Intervention
ACTIVE NOT RECRUITING · NA
-
Improving Drug Adherence Among Adolescents in Uganda Using SMS Reminders
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.